• 대한임상검사과학회지
• /
• 제55권4호
• /
• pp.261-268
• /
• 2023

[¹⁸F]Fluorocholine은 임상에서 부갑상선 선종, 전립선암 및 간세포암 진단 등에 사용되는 PET용 콜린 방사성의약품이다. 본 연구에서는 고체상 추출 카트리지법을 방사성의약품 자동합성장치에 적용하여 [¹⁸F]fluorocholine을 제조하는 방법을 최적화하였다. [¹⁸F]Fluorocholine은 하나의 반응용기를 사용하여 두 단계 표지반응으로 합성하였으며, [¹⁸F]fluorocholine 합성과정 중 생성되는 불순물을 제거하기 위해 사용하는 SepPak^Ⓡ Silica 카트리지의 개수를 3개로 최적화하였고, 전구 물질인 DMAE를 10%로 희석하였을 때 가장 높은 방사화학적 수율을 획득 할 수 있었다. 또한 최종 생산된 [¹⁸F] fluorocholine 주사액은 유럽약전에 명시된 품질관리기준을 모두 만족하였다. 본 연구를 통해 쉽고 간편하게 사용할 수 있는 고체상 추출 카트리지를 사용하여 방사성의약품 자동합성장치에 최적화한 [¹⁸F]fluorocholine의 합성법은 임상 현장에 안정적으로 [¹⁸F]fluorocholine을 공급하는데 유용하게 사용될 것으로 사료된다.

• 약학회지
• /
• 제46권6호
• /
• pp.392-397
• /
• 2002

A simple and sensitive high performance liquid chromatographic method to quantitate ursodeoxycholic acid in crude drug pharmaceuticals was investigated. Ursodeoxycholic acid react with 2-bromoacetyl-6-methoxynaphthalene (Br-AMN) in the presence of triethylamine to form highly fluorescent derivative. The derivatization procedure was performed at 7$0^{\circ}C$ and completed within 30 min. The optimal wavelength of the fluorescence detector are λ$_{ex}$=300 nm and λ$_{em}$ = 460 nm. The LOD of the ursodeoxycholic acid was 25 ng/mι based on the S/N =3, and the LOQ was 80 ng/mι based on S/N = 10. Crude drug pharmaceuticals pretreated by solid phase extraction (Sep-pak $C_{18}$ cartridge) which were shown very good separation and recovery values for the compound.d.

• Mass Spectrometry Letters
• /
• 제13권4호
• /
• pp.158-165
• /
• 2022

Many therapeutic class drugs such as beta-blocker, corticosteroids, NSAIDs, etc are prohibited substances in the horse racing industry. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) technology makes it possible to isolate drugs from interference, enables various drug analyses in complex biological samples due to its sensitive sensitivity, and has been successfully applied to doping control. In this paper, we describe a rapid and sensitive method based on solid-phase extraction (SPE) using solid phase cartridge and LC-MS/MS to screen for different class's 35 drug targets in equine plasma. Plasma samples were pretreated by SPE with the NEXUS cartridge consisted non-polar carbon resin and minimum buffer solvent. Chromatographic separation of the analytes was performed on ACQUITY HSS C18 column (2.1 × 150 mm, 1.8 ㎛). The elution gradient was conducted with 5 mM ammonium formate (pH 3.0) in distilled water and 0.1% formic acid in acetonitrile at a flow rate of 0.25 mL/min. The selected reaction monitoring (SRM) mode was used for drug screening with multiple transitions in the positive ionization mode. The specificity, limit of detection, recovery, and stability was evaluated for validation. The method was found to be sensitive and reproducible for drug screening. The method was applied to plasma sample analysis for the proficiency test from the Association of Racing Chemist.

• 한국물환경학회지
• /
• 제25권5호
• /
• pp.720-726
• /
• 2009

We investigated the most effective pre-treatment processes and LC/MS/MS condition for microcystins analysis. With a step-by-step pre-treatment, efficiencies of several established methods were compared. At the level of cell burst, sonication method was found to be the most efficient. As a mycrocystins first extraction solvent, 5% acetic acid showed the highest efficiency. An isolation and recovery rate of mycrocystins of ODS Sep-Pak $C_{18}$ cartridge was higher than HLB SPE cartridge. As a final elution solvent from cartridge, 100% MeOH had a better efficiency than others. Using a LC/MS/MS, effective analytical methods were established. C18 reverse column was used and gradient elution was performed with using acetonitrile, 0.1% formic acid as a mobile phase. We analysed to 0.8 mL/min flow rate fit to the $5{\mu}m$ particle size column and $55^{\circ}C$ housing temperature. The validity of established analytical method was evaluated that MDL as average $0.050{\pm}0.014{\mu}g/L$ and LOQ as average $0.160{\pm}0.045{\mu}g/L$ had a good sensitivity over 40 magnification rather than $2{\mu}g/L$ detection limit of HPLC.

• 분석과학
• /
• 제23권5호
• /
• pp.437-445
• /
• 2010

본 연구에서는 동물용 의약품으로 널리 사용되고 환경 중 잔류 가능성이 높은 설폰아미드계 항생제 5종 (sulfadiazine, sulfamerazine, sulfamethazine, sulfamethoxazole, sulfathiazole) 및 대사체 5종($N^4$-acetylsulfadiazine, $N^4$-acetylsulfamerazine, $N^4$--acetylsulfamethazine, N4-acetylsulfamethoxazole, sulfamethoxazole-$N^1$-glucuronide)의 분석방법을 연구하였다. 다양한 전처리 조건을 비교 검토하여 최적의 동시 추출방법과 LC/ESI-MS/MS를 이용한 기기분석 조건을 확립하였다. 카트리지별 추출효율은 C18 카트리지에서 12~94%, HLB 카트리지에서 60-95%, MCX 카트리지에서 25-123%였으며, MCX와 HLB 카트리지를 결합한 방법의 회수율은 70-90%이었다. HLB를 선택하여 확립된 분석방법의 회수율은 66~115%, 상대표준편차 5~17%이었으며, 방법검출한계는 0.001~0.187 ng/mL 였다. 이를 실제 환경시료에 적용한 결과 4종의 설폰아미드 항생제가 0.008~2.153 ng/mL 농도범위로 검출되었으며, 대사체의 경우 $N^4$-acetylsulfamethoxazole이 확인되었으나 검출한계 미만으로 관찰되었다.

• Bulletin of the Korean Chemical Society
• /
• 제28권2호
• /
• pp.276-280
• /
• 2007

In this work, caffeine and some catechin compounds + C, EC, EGC, and EGCG were extracted from green tea by using molecular imprinted polymers (MIP) as sorbent materials in a solid-phase extraction (SPE) process known as MISPE (molecular imprinted solid-phase extraction). For synthesis of MIP, caffeine was employed as the template, MAA as the monomer, EGDMA as the crosslinker, and AIBN as the initiator. A solution of caffeine (0.2 mg/mL in methanol) was utilized in the solid extraction cartridges following loading, washing, and elution procedures with acetonitrile, methanol, and methanol-acetic acid (90/10, %v/v) as the solvents, respectively. This solid-phase extraction protocol was applied for the extraction of caffeine and some catechin compounds from green tea. A comparison was made between the results obtained with the MIP cartridges and a traditional C18 reversed-phase cartridge. It was thereupon found that the recovery of caffeine by the MIPbased sorbent used in this work was almost two and four times greater than that by a commercially available C18 material. A quantitative analysis was conducted by high performance liquid chromatography (HPLC) using a C18 column (5 μm, 250 × 4.6 mm) with methanol/water (40/60, %v/v) as the mobile phase at a flow rate of 0.5 mL/min.

• 한국환경농학회지
• /
• 제23권4호
• /
• pp.251-257
• /
• 2004

Analytical methods were developed to determine cyclosulfamuron residues in soil, water, rice grain and straw using high-performance liquid chromatography (HPLC) with ultraviolet absorption detection. In these methods, cyclosulfamuron was extracted with aqueous $Na_2HPO_4$/acetone and acetone/methanol mixture from soil and rice samples respectively. Liquid-liquid partition coupled with ion-associated technique, Florisil column chromatography, and solid-phase extraction (SPE) were used to separate cyclosulfamuron from interfering co-extractives prior to HPLC analysis. For water sample, the residue was enriched in $C_{18}$-SPE cartridge, cleaned up in situ, and directly subjected to HPLC. Reverse-phase HPLC under ion-suppression was successfully applied to determine cyclo-sulfamuron in sample extracts with the detection at its ${\lambda}_{max}$ (254 nm). Recoveries from fortified samples averaged $87.8{\pm}7.1%$ (n=12), $97.3{\pm}7.2%$ (n=12), $90.8{\pm}6.6%$ (n=6), and $78.5{\pm}6.7%$ (n=6) for soil, water, rice grain and straw, respectively. Detection limits of the methods were 0.004 mg/kg, 0.001 mg/L, 0.01 mg/kg and 0.02 mg/kg for soil, water, rice grain and straw samples, respectively.

• Food Science and Biotechnology
• /
• 제18권2호
• /
• pp.565-569
• /
• 2009

This study was conducted to evaluate the effects of different preparation methods on the recovery and quantification of ginsenosides in raw Korean ginseng (Panax ginseng C.A. Meyer). Eight major ginsenosides ($Rb_1$, $Rb_2$, $Rb_3$, Rc, Rd, Re, Rf, and $Rg_1$) were analyzed by high performance liquid chromatography (HPLC), after which the recovery and repeatability of the extraction of those ginsenosides using 3 different preparation methods were compared [A. direct extraction (DE) method, hot MeOH extraction/evaporation/direct dissolution; B. solid phase extraction (SPE) method, hot MeOH extraction/evaporation/dissolution/$C_{18}$ cartridge adsorption/MeOH elution; C. liquid-liquid extraction (LLE) method, hot MeOH extraction/evaporation/dissolution/n-BuOH fractionation]. Use of the DE method resulted in a significantly higher recovery of total ginsenosides than other methods and a relatively clear peak resolution. Use of the SPE and LLE methods resulted in clearer peak resolution, but lower ginsenoside recovery than the DE method. The LLE method showed the lowest ginsenoside recovery and repeatability among the 3 methods. Given that the DE method employed only extraction, evaporation, and a dissolution step (avoiding complicate and time consuming purification), this technique may be an effective method for the preparation and quantification of ginsenosides from raw Korean ginseng.

• 핵의학기술
• /
• 제22권1호
• /
• pp.51-54
• /
• 2018

본 연구는 타우 PET용 방사성의약품으로 개발된 $^{18}F-THK5351$의 임상적용을 위하여 상용화된 자동 합성장치에 적용한 표지방법을 개발하고자 하였다. $^{18}F-THK5351$의 표지법 개발은 HPLC 분리정제 전 표지반응물의 유기용매, 불순물 및 미반응 물질을 제거하기 위해 고체상 추출 카트리지를 사용하여 정제하는 과정을 포함한 방법(method I)과 전처리 정제과정을 포함하지 않은 방법(method II)으로 나누어 진행하였다. $^{18}F-THK5351$ 표지는 $Sep-Pak^{(R)}$ QMA 카트리지를 사용하여 흡착한 불소-18 음이온을 $K_{2.2.2}/K_2CO_3$으로 용출한 후 $100^{\circ}C$에서 진공상태와 헬륨의 흐름하에 건조한 후 표지 전구체와 $110^{\circ}C$에서 10분간 반응시켰다. 반응 후 1 N HCl을 첨가하여 보호기를 제거한 후 0.8 M $CH_3COOK$를 사용하여 표지 반응물을 중화하였다. 이후 전처리 정제의 유무에 따라 method I과 method II로 진행하였다. Method I에서 전처리 정제 과정의 최적화를 위해 $Sep-Pak^{(R)}$ tC18과 $Oasis^{(R)}$ HLB 고체상 추출 카트리지를 사용하여 비교한 결과 $Sep-Pak^{(R)}$ tC18 카트리지는 57.2%의 표지 반응물이 빠져 나갔고, $Oasis^{(R)}$ HLB 카트리지는 40.6%의 표지 반응물이 빠져나가는 것을 확인할 수 있었다. Method I 표지방법의 방사화학적 수율은 $23.8{\pm}1.9%$(decay-corrected, n=4) 이었고, method II 표지방법의 방사화학적 수율은 $31.9{\pm}6.7%$(decay-corrected, n=10) 이었다. 본 연구를 통해 전처리 정제과정을 거쳐 HPLC로 분리정제하는 방법과 전처리 정제과정을 거치지 않고 표지반응물을 바로 HPLC 정제하는 표지방법을 상용화된 자동합성장치를 사용하여 성공적으로 개발하였다. 하지만 전처리 정제과정을 포함한 표지방법은 표지반응물의 손실이 많아 방사화학적 수율이 낮아지는 단점을 발견하였다. 본 연구에서 개발된 전처리 정제과정이 생략된 $^{18}F-THK5351$의 표지방법은 향후 통상적으로 생산 시 보다 유용한 표지방법으로 사용될 것으로 기대된다.

• Archives of Pharmacal Research
• /
• 제28권4호
• /
• pp.463-468
• /
• 2005

The purpose of the present study was to develop a standard protocol for imidapril hydrochloride bioequivalence testing. For this reason, a specific LC-MS method was developed and validated for the determination of imidapril in human plasma. A solid-phase extraction cartridge, $Sep-pak^{R}$ C18, was used to extract imidapril and ramipril (an internal standard) from deproteinized plasma. The compounds were separated using a XTerra $MS^{R}$?C18 column ($3.5 {\mu}m, 2.1\times150 mm$) and $acetonitrile-0.1\%$ formic acid (67:33, v/v) adjusted to pH 2.4 by 2 mmol/L ammonium formic acid, as mobile phase at 0.3 mL/min. Imidapril was detected as m/z 406 at a retention time of ca. 2.3 min, and ramipril as m/z 417 at ca. 3.6 min. The described method showed acceptable specificity, linearity from 0.5 to 100 ng/mL, precision (expressed as a relative standard deviation of less than $15\%$), accuracy, and stability. The plasma concentration-versus-time curves of eight healthy male volunteers administered a single dose of imidapril (10 mg), gave an $AUC_{12hr}$ of imidapril of $121.48\pm35.81 ng mL^{-1} h$, and $C_{max} and T_{max}$ values of $32.59\pm9.76 ng/mL and 1.75\pm0.27 h$. The developed method should be useful for the determination of imidapril in plasma with sufficient sensitivity and specificity in bioequivalence study.